OBJECTIVES: To determine whether patient sex has a significant effect on long-term outcomes post curative resection of non-small-cell lung cancer.
INTRODUCTION
It is thought that females have a better long-term survival with non-small-cell lung cancer regardless of their stage [1] [2] [3] .
Lung cancer has different risk factors determining survival depending on stage, and previous work has identified sex as being important only in early-stage lung cancer; however, this work was not risk adjusted [4] . That there are differing factors determining long-term survival for each stage means that separate analysis by stage as well as additional techniques to conventional Cox regression may need to be used.
The issue is compounded by the known increased life expectancy of females secondary to their natural life span [5, 6] . This means that long-term survival post potentially curative resections for non-small-cell lung cancer may not be due the biological cancer behaviour in females, but innate survival.
We investigated the effect of sex, after adjusting for life expectancy on long-term survival in patients with potentially curative non-small-cell lung cancer.
METHODS

Ethics
Local institutional ethics board approval was obtained for this study.
Methodology
We retrospectively analysed a prospectively validated thoracic surgery database (n = 4212), from a single institution, from September 2001 to October 2012. The demographics of the study population are shown in Table 1 . All patients included in our analysis underwent an R0 resection.
Staging
Staging was defined as pathological staging to eliminate bias by 'better' preoperative staging due to current multislice CT and PET scanning. Routine intraoperative mediastinal lymph node sampling has always been undertaken in our unit. PET scanning became routine for all patients 5 years ago in our unit. All patients with mediastinal lymph nodes enlarged by CT criteria (>10 mm in the short axis) or avid on PET were biopsied preoperatively via mediastinoscopy, mediastinotomy or endobronchial ultrasound.
Follow-up
Survival data for all patients are routinely obtained through the National Strategic Tracing Service, as previously described [7] .
Benchmarking
We benchmarked our 5-year survival against the 6th International Association for the Study of Lung Cancer (IALSC) [8] .
Life expectancy. As females live longer than males in the United Kingdom, we attempted to adjust for this potentially confounding factor by the utilization of the national life expectancy tables (http://www.statistics.gov.uk/hub/population/ index.html). Each patient was matched by age and sex to determine their average life expectancy [9, 10] . This derived variable was utilized as a separate covariants in the analyses.
Univariate analysis
Kaplan-Meier survival curves for Stages I, II and IIIa were constructed to examine the effect of sex on survival. In addition Kaplan-Meier survival curves were constructed for squamous carcinoma and adenocarcinoma histology subtypes.
Multivariate analysis
Univariate analysis of all variables was performed first, with the objective of identifying significant factors for inclusion in a multivariate Cox regression model. Cox proportional hazards regression analysis was utilized for the study population and each stage separately, as previous work has identified different factors as being significant for each stage [11] . The enter method of variable selection was utilized to demonstrate the P-values associated with non-significant variables. Stepwise Cox proportional hazards regression analysis was also utilized to confirm that the significant factors identified by the enter method were correct. The entry criterion was P < 0.05, and the removal criterion was P > 0.1. Cox risk-adjusted survival curves were created to demonstrate the effect of sex on long-term survival, Fig. 2 . The covariates were plotted at their mean. All analyses had the following variables included: age, sex, life expectancy, FEV1, New York Heart Association (NYHA) grade, smoking status-current, ex, non, pack years, alcohol consumption-units, chronic obstructive pulmonary disease (COPD), hypertension, diabetes-diet, oral, insulin, T stage, N stage, histology-adenocarcinoma, squamous carcinoma, operative intervention-pneumonectomy, lobectomy, wedge and body mass index (BMI).
Propensity analysis
Logistic regression for group membership of female sex, regardless of outcome, was used to calculate the propensity score for A dotplot of standardized mean differences (Cohen's d) for all covariates before and after matching, Kaplan-Meier and Cox post propensity matching survival curves were created. The propensity matching was repeated just for adenocarcinoma and squamous carcinoma.
Statistical software
All statistical analysis other than the neuronal network and propensity matching were performed with MedCalc for Windows, (version 12.1.4, MedCalc Software, Mariakerke, Belgium). Propensity matching was performed with SPSS (version 20.0 for Windows, SPSS, Inc., Chicago IL, USA), SPSS Statistics Integration Plug-In for R and R 2.12.2. Table 1 demonstrates the preoperative, operative and postoperative details of our study population. One hundred percent follow-up was achieved due to the National Strategic Tracing Service that operates in the United Kingdom. Overall institutional in-hospital mortality was 2.0% for all thoracic resections. Median survival was 2.78 years (range 0-13 years). Two thousand two hundred and thirty-three males and 1979 females were included in the study.
RESULTS
Study population
Benchmarking
Benchmarking against the 6th IALSC results failed to demonstrate any significant differences.
Life expectancy
The predicted life expectancy of our study cohort, after matching for age and sex against the UK population figures, averaged 17.7 years (minimum 1.6, maximum 64.8, standard deviation 9).
Univariate analysis
Survival of all patients stratified by sex demonstrated superior survival of females for all stages, P = 0.0003, and Stage I, P = 0.0006, Fig. 1A and B. Female sex conferred no survival advantage in Stage II, P = 0.7, and IIIa, P = 0.1, Fig. 1C and D, respectively. Sub-analysis by histological type demonstrated that females had superior survival with adenocarcinoma compared with males, P < 0.001, but no sex difference existed with squamous carcinomas, P = 0.2, Fig. 2A and B, respectively. 
Cox multivariate analysis
Cox analyses demonstrated that female sex was an advantageous prognostic factor for the entire study group [hazard ration (HR) 0.82, 95% confidence interval (CI) 0.69-0.96], and Stage I only (HR 0.70, 95% CI 0.57-0.63), Fig. 3A and B. Sex was of no significant importance in Stage II and IIIa disease with regard to survival. The odds ratios for the separate analyses are shown in Table 2 . Stepwise and enter methodology for regression analysis identified the same significant factors.
The Cox regression analysis was repeated for just adenocarcinoma patients and squamous carcinoma patients. Female sex was not a significant factor determining survival in patients with squamous carcinoma; however, it was significantly associated with increased survival in patients with adenocarcinoma, (HR 0.63, 95% CI 0.51-0.78), Table 2 . Survival at the mean of the covariates is shown in Fig. 3 for patients with adenocarcinoma.
Propensity analysis
Nine hundred and sixty-seven female patients were matched 1:1 with male controls. The Dotplot of standardized mean differences (Cohen's d) for all covariates before and after matching is shown in Fig. 4 . Kaplan-Meier survival of the whole-matched group demonstrated that female sex was significantly associated with an increased long-term survival, P < 0.001, Fig. 5A . KaplanMeier survival of adenocarcinoma only patients demonstrated that female sex was significantly associated with an increased long-term survival, P < 0.001, Fig. 5B . Kaplan-Meier survival of squamous carcinoma only patients demonstrated sex was not a significant factor affecting long-term survival, P = 0.9.
The Dotplot of standardized mean differences demonstrated that an imperfect match was obtained, overall χ 2 balance test χ 2 (18) = 69.9, P < 0.001, due to age, P = 0.0002, and FEV1, P < 0.001, (full propensity-matched details can be seen in Supplementary Material), this necessitated a Cox regression analysis on the propensity-matched dataset with tumour stage, histology, sex, FEV1 and age as covariates. This revealed that female sex was associated with improved survival in the study group, P < 0.0001, Fig. 5C , and in patients with adenocarcinoma, P < 0.0001, Fig. 5D , but not in patients with squamous carcinoma, Table 3 . 
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Two further propensity matches were performed on patients with squamous carcinoma and those with adenocarcinoma. Kaplan-Meier and Cox regression analyses concurred with the above findings (data not shown).
Confounding factor analysis
Wedge resections are non-anatomical and may confound analysis. All analyses ( pre-and post propensity-matched KaplanMeier and Cox multivariate) were repeated with wedge resections excluded. The results were identical with regard to the findings with respect to females (data not shown).
DISCUSSION
Female sex is associated with increased long-term survival in patients undergoing potentially curative resections for Stage I non-small-cell carcinoma, if they have adenocarcinoma, but not squamous carcinoma.
Female sex is frequently heralded a favourable prognostic factor with regard to lung cancer [12] [13] [14] [15] . Explanations include hormonal milieu, which is known to affect long-term survival [16] . As the vast majority of female lung cancer patients are postmenopausal, this seems unlikely as an explanation for the observed difference. Known prognostic factors such as smoking status, histological subtypes and alcohol consumption differ between males and females, potentially biasing the interpretation of results [17] .
Univariate analysis clearly demonstrated a significant survival advantage for female patients who have adenocarcinoma, but not squamous carcinomas. The use of multivariate analysis and propensity risk factor matching confirmed the univariate analysis results. A number of previous studies of sex-dependent survival have failed to adjust for the histology type, differing stages and All analyses had the following variables included: age, sex, life expectancy, FEV1, New York Heart Association (NYHA) grade, smoking status-current, ex, non, pack years, alcohol consumptionunits, chronic obstructive pulmonary disease (COPD), hypertension, diabetes-diet, oral, insulin, T stage, N stage, histologyadenocarcinoma, squamous carcinoma, operative interventionpneumonectomy, lobectomy, wedge and body mass index. Female sex is the only non-significant variable shown. risk factors that females possess, confounding their results or have been underpowered. We can only speculate that females have different genetic profile adenocarcinoma compared with males, as we do not have epidermal growth factor receptor (EGFR) mutations status on the vast majority of the study cohort.
Patients die from causes other than lung cancer especially in Stage I cases and the elderly. Stage I is particularly likely to be biased by non-cancer deaths as patients are statistically more likely to be cured and have a long life expectancy. Stage IIIa patients have a poor prognosis, despite seemingly successful surgery, which is associated with a poor long-term survival, so concomitant medical conditions become less important with regard to survival. This is the basis of actual and actuarial survival [18] . Separate multivariate analysis by stage demonstrated this.
Stage I disease accounted for the majority of patients potentially skewing the study group and conclusions. In addition to stage skew, risk factors are known to be different between men and women. For instance, the incidence of pneumonectomy between males and females was different, potentially skewing analysis by Cox regression.
Life expectancy based on national population statistics depends on a subject's age and sex, and is just a crude estimate. As our study was large, the errors associated with population statistics become lower, but are still present. We initially hypothesized that natural longer female life expectancy may explain why Cox regression analyses identify sex as an important prognostic factor; however, our analysis demonstrates that it is not a significant factor, regardless of stage. This may be due to the short natural survival time of patients with non-small-cell lung cancer (median survival <3 years).
Kaplan-Meier survival analysis is the most commonly utilized survival statistic methodology used after propensity matching. As an exact propensity match was not possible based, due to age, a Figure 5 : Survival analysis of propensity-matched dataset. Kaplan-Meier survival of (A) whole group, P < 0.001, (B) adenocarcinoma only, P < 0.001, (C) squamous carcinoma only, P = 0.9, and (D) Cox regression analysis plotted at the mean of covariates for patients with adenocarcinoma P < 0.001. Cox multivariate analysis was needed post matching. Caution into interpreting significance of Cox covariate values utilized in the propensity matching methodology is needed, but as only female sex, which is not a matched term, was interpreted, our methodology was valid [19, 20] . The differential effect of sex on long-term survival depending on histological subtype and stage raises an issue with regard to updating the TNM classification system that is not sex or histological subtype dependent.
LIMITATIONS
This is a retrospective analysis and should be interpreted as such. Despite a seemingly large cohort being analysed, the results need to be confirmed or refuted by other groups. We do not have EGFR mutation status on the adenocarcinoma subgroup to interpret why females with an adenocarcinoma have improved long-term survival.
CONCLUSIONS
Propensity matching and Cox multivariate regression analysis confirmed the univariate finding that female sex is only associated with improved survival in patients with Stage I adenocarcinoma. Patient sex does not affect survival of patients with squamous carcinoma.
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